
17/05/2025
*Use of metformin in adults with diabetes linked to lower risk of long COVID*
A recent NIH-funded study shows that adults with type 2 diabetes who take metformin have a lower risk of developing long COVID or dying from a COVID-19 infection compared to those taking other anti-diabetes medications. The study, which analyzed health data from nearly 38 million Americans, found a 13-21% reduction in long COVID or death in metformin users. This builds on earlier research showing metformin reduced long COVID risk by 40% in non-diabetic adults. The exact mechanism remains unclear but may involve reduced inflammation and viral levels. Metformin should only be used under medical supervision!